Improving distress perception and mutuality in migraine caregivers after 6 months of galcanezumab treatment

OBJECTIVE: This prospective cohort, real‐life study aimed to evaluate whether galcanezumab, a monoclonal antibody anti‐calcitonin gene‐related peptide (CGRP) ligand, can reduce caregivers' distress and improve their mutuality with patients. BACKGROUND: Migraine is a highly disabling chronic dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Fofi, Luisa, Altamura, Claudia, Fiorentini, Giulia, Brunelli, Nicoletta, Marcosano, Marilena, Barbanti, Piero, Vernieri, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828231/
https://www.ncbi.nlm.nih.gov/pubmed/36205100
http://dx.doi.org/10.1111/head.14400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828231/
https://www.ncbi.nlm.nih.gov/pubmed/36205100
http://dx.doi.org/10.1111/head.14400

Ejemplares similares